MedTrace Logo

Fibergraft Interbody Fusion Retrospective

NCT03898232 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2021-01-29

No results posted yet for this study

Summary

A single center study of clinical and radiological outcomes in a retrospective cohort of patients treated with Lumbar Interbody Fusion augmented with Prosidyan Fibergraft for 1 or 2 level degenerative spinal disease by a single surgeon.

Study Design: Retrospective chart review with prospective data collection.

Conditions

  • Degenerative Disc Disease
  • Degenerative Spondylolisthesis
  • Spinal Degeneration
  • Spinal Stenosis

Interventions

RADIATION

Computed Tomography (CT) Scan of the Lumbar Spine

Patients in the cohort who have not received a 12 month post-op CT scan will be asked to enroll in the study and undergo a CT of the lumbar spine.

Sponsors & Collaborators

  • Bone and Joint Clinic of Baton Rouge

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-09
Primary Completion
2020-02-20
Completion
2020-02-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03898232 on ClinicalTrials.gov